Precision annotation of digital samples in NCBI's gene expression omnibus

Scientific Data

Volumn 4, Issue , 2017, Pages

  Hadley, Dexter ^a   Pan, James ^b   El Sayed, Osama ^c   Aljabban, Jihad ^d   Aljabban, Imad ^d   Azad, Tej D ^b   Hadied, Mohamad O ^e   Raza, Shuaib ^f   Rayikanti, Benjamin Abhishek ^g   Chen, Bin ^a,h   Paik, Hyojung ^a   Aran, Dvir ^a   Spatz, Jordan ^a   Himmelstein, Daniel ^a   Panahiazar, Maryam ^a   Bhattacharya, Sanchita ^a   Sirota, Marina ^a   Musen, Mark A ^b   Butte, Atul J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g FLETCHER ALLEN HEALTH CARE   (United States)

^h Korea Institute of Science and Technology Information (KISTI)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; GENETIC DATABASE; HUMAN; INFORMATION PROCESSING;

DATA CURATION; DATABASES, GENETIC; GENE EXPRESSION; HUMANS;

EID: 85029632961     PISSN: None     EISSN: 20524463     Source Type: Journal    
DOI: 10.1038/sdata.2017.125     Document Type: Article

References (53)

1. Chen, R. & Snyder, M. Promise of personalized omics to precision medicine. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 5, 73-82 (2013).
2. Highnam, G. & Mittelman, D. Personal genomes and precision medicine. Genome Biol 13, 324 (2012).
3. Khoury, M. J., Gwinn, M. L., Glasgow, R. E. & Kramer, B. S. A population approach to precision medicine. American Journal of Preventive Medicine 42, 639-645 (2012).
4. Mirnezami, R., Nicholson, J. & Darzi, A. Preparing for Precision Medicine. New England Journal of Medicine 366, 489-491 (2012).
5. Robinson, P. N. Deep phenotyping for precision medicine. Human Mutation 33, 777-780 (2012).
6. Roden, D. M. & Tyndale, R. F. Genomic medicine, precision medicine, personalized medicine: what's in a name? Clin. Pharmacol. Ther. 94, 169-172 (2013).
7. Butte, A. J. & Ohno-Machado, L. Making it personal: translational bioinformatics. J. Am. Med. Inform. Assoc 20, 595-596 (2013).
8. Farnier, M. PCSK9: From discovery to therapeutic applications. Arch. Cardiovasc. Dis. 107, 58-66 (2014).
9. Cohen, J. et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 37, 161-165 (2005).
10. Abifadel, M. et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 34, 154-156 (2003).
11. Stein, E. A. et al. Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. N. Engl. J. Med. 366, 1108-1118 (2012).
12. Hadley, D. et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nat. Commun 5, 4074 (2014).
13. Elia, J. et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat. Genet. 44, 78-84 (2012).
14. National Research Council (US). Committee on A Framework for Developing a New Taxonomy of Disease. Toward Precision Medicine. The National Academies Press (National Academies Press, 2011).
15. Mailman, M. D. et al. The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet. 39, 1181-1186 (2007).
16. Bhattacharya, S. et al. ImmPort: disseminating data to the public for the future of immunology. Immunol. Res. 58, 234-239 (2014).
17. Rustici, G. et al. ArrayExpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res. 41, D987-D990 (2013).
18. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res. 39, D1005-D1010 (2011).
19. Barrett, T. et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-D995 (2013).
20. Barrett, T. et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res. 37, D885-D890 (2009).
21. Wilkinson, M. D. et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci. Data 3, 160018 (2016).
22. Malone, J. et al. Modeling sample variables with an Experimental Factor Ontology. Bioinformatics 26, 1112-1118 (2010).
23. Amar, D., Hait, T., Izraeli, S. & Shamir, R. Integrated analysis of numerous heterogeneous gene expression profiles for detecting robust disease-specific biomarkers and proposing drug targets. Nucleic Acids Res. 43, 7779-7789 (2015).
24. Wang, Z. et al. Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd. Nat. Commun 7, 12846 (2016).
25. Zheng, H., Li, D. & Hou, W. Task Design, Motivation, and Participation in Crowdsourcing Contests. Int. J. Electron. Commer. 15, 57-88 (2011).
26. Noy, N. F. et al. BioPortal: ontologies and integrated data resources at the click of a mouse. Nucleic Acids Res. 37, W170-W173 (2009).
27. Maglott, D., Ostell, J., Pruitt, K. D. & Tatusova, T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 39, D52-D57 (2011).
28. Kleene, S. S. C. Automata Studies. in (eds. Shannon, C. E. & McCarthy, J.) 3-41 (Princeton University Press, 1956).
29. Schriml, L. M. et al. Disease ontology: A backbone for disease semantic integration. Nucleic Acids Res. 40, D940-D946 (2012).
30. Kibbe, W. A. et al. Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res. 43, D1071-D1078 (2015).
31. Sim, J. & Wright, C. C. The Kappa Statistic in Reliability Studies: Use, Interpretation, and Sample Size Requirements. Phys. Ther. 85, 257-268 (2005).
32. Viera, A. J. & Garrett, J. M. Understanding interobserver agreement: The kappa statistic. Fam. Med. 37, 360-363 (2005).
33. Landis, J. R. & Koch, G. G. The measurement of observer agreement for categorical data. Biometrics 33, 159-174 (1977).
34. Weinstein, J. N. et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120 (2013).
35. Dudley, J. T., Schadt, E., Sirota, M., Butte, A. J. & Ashley, E. Drug discovery in a multidimensional world: systems, patterns, and networks. J. Cardiovasc. Transl. Res. 3, 438-447 (2010).
36. Chen, R. et al. Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput. Biol. 6, e1000940 (2010).
37. Vicent, S. et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res. 72, 5744-5756 (2012).
38. Sharaf, R. N. et al. Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes. BMC Gastroenterol. 11, 5 (2011).
39. Butte, A. A. J., Sigdel, T. K. T., Wadia, P. P. P., Miklos, D. B. & Sarwal, M. M. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease. Mol. Cell. Proteomics 10, M110.000497 (2011).
40. Wen, Q. et al. Peptidomic Identification of Serum Peptides Diagnosing Preeclampsia. PLoS ONE 8, e65571 (2013).
41. Liu, L. Y. et al. Integrating multiple 'omics' analyses identifies serological protein biomarkers for preeclampsia. BMC Med. 11, 236 (2013).
42. Sweeney, T. E., Shidham, A., Wong, H. R. & Khatri, P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci. Transl. Med. 7, 287ra71 (2015).
43. Hessel, S. J., Herman, P. G. & Swensson, R. G. Improving performance by multiple interpretations of chest radiographs: effectiveness and cost. Radiology 127, 589-594 (1978).
44. Kraemer, H. C. How many raters? toward the most reliable diagnostic consensus. Stat. Med. 11, 317-331 (1992).
45. Metz, C. E. & Shen, J. H. Gains in accuracy from replicated readings of diagnostic images: prediction and assessment in terms of ROC analysis. Med. Decis. Making 12, 60-75 (1992).
46. Weller, S. C. & Mann, N. C. Assessing rater performance without a 'gold standard' using consensus theory. Med. Decis. Making 17, 71-79 (1997).
47. Wu, C., MacLeod, I. & Su, A. I. BioGPS and MyGene.info: Organizing online, gene-centric information. Nucleic Acids Res. 41, 561-565 (2013).
48. Choi, J. K., Yu, U., Kim, S. & Yoo, O. J. Combining multiple microarray studies and modeling interstudy variation. Bioinformatics 19, i84-i90 (2003).
49. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177-188 (1986).
50. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
51. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
52. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289-300 (1995).
53. Xiao, Y. et al. A novel significance score for gene selection and ranking. Bioinformatics 30, 801-807 (2014).